Technology | November 15, 2006

Thrombectomy Catheter Boasts Clot Removing Power; Tip, Hub Improvements


The AngioJet SpiroflexVG Rheolytic Thrombectomy catheter is the first AngioJet catheter of its size to be offered in a Rapid Exchange platform.
Utilizing its proprietary Spiroflex shaft technology, the Spiroflex VG catheter benefits from several design improvements made to the most recent generation of Possis Medical products. The catheter offers improved trackability inside the vessel and includes tip and hub improvements found on the recently introduced Spiroflex catheter. The Spiroflex VG Catheter is fully released for sale in the U.S. for peripheral use.
Possis also recently announced that its Fetch Aspiration Catheter has received 510(k) clearance from the FDA. Using catheter technology from the company's AngioJet Rheolytic Thrombectomy System, Fetch offers physicians another alternative for the aspiration of small, fresh blood clots (thrombus) and other embolic debris from arteries.
Fetch uses an industry-standard syringe as its aspiration source, and provides flexibility and handling needed for interventional procedures.


Additional Content

News | Catheters

Nov. 4, 2026 — Evident Vascular has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident ...

Home November 05, 2026
Home
News | Catheters

Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...

Home September 15, 2026
Home
News | Catheters

June 30, 2026 — Penumbra Inc. has received the CE Mark for Red 72 Silver Label and Red 72 Silver Label with SENDit ...

Home July 02, 2026
Home
News | Catheters

Feb. 12, 2026 – CellProthera has acquired the transendocardial catheter originally developed by Celyad Oncology. This ...

Home February 12, 2026
Home
News | Catheters

Oct. 23, 2025— Emboline, Inc., a provider of full-body embolic protection devices for transcatheter procedures, thas ...

Home October 28, 2025
Home
Subscribe Now